Bruker (NASDAQ:BRKR – Get Rating) updated its FY23 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $2.55-2.60 for the period, compared to the consensus estimate of $2.56. The company issued revenue guidance of $2.83-2.88 billion, compared to the consensus revenue estimate of $2.83 billion. Bruker also updated its FY 2023 […]
Bruker (NASDAQ:BRKR – Get Rating) announced its earnings results on Thursday. The medical research company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.55 by $0.09, Briefing.com reports. Bruker had a net margin of 11.89% and a return on equity of 34.71%. The business had revenue of $685.30 million during the quarter, […]
Texas Permanent School Fund trimmed its holdings in shares of Bruker Co. (NASDAQ:BRKR – Get Rating) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 67,240 shares of the medical research company’s stock after selling 5,209 shares during the quarter. Texas Permanent […]
Bruker Co. (NASDAQ:BRKR – Get Rating) CEO Frank H. Laukien sold 82,795 shares of the stock in a transaction on Monday, May 1st. The shares were sold at an average price of $78.75, for a total transaction of $6,520,106.25. Following the completion of the transaction, the chief executive officer now owns 38,262,287 shares of the […]
Bruker (NASDAQ:BRKR – Get Rating) posted its earnings results on Thursday. The medical research company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.09, Briefing.com reports. Bruker had a return on equity of 34.13% and a net margin of 11.72%. The firm had revenue of $685.30 million for the quarter, […]